Ternary amorphous composites of celecoxib, poly(vinyl pyrrolidone) and meglumine with enhanced solubility

Pharmazie

Volumn 60, Issue 11, 2005, Pages 830-836

  Gupta, P ^a   Bansal, Arvind K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; MEGLUMINE; POVIDONE;

AQUEOUS SOLUTION; ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; MICROSCOPY; MOLECULAR INTERACTION; TEMPERATURE DEPENDENCE; THERMODYNAMICS; THERMOSTABILITY;

CALORIMETRY, DIFFERENTIAL SCANNING; CYCLOOXYGENASE 2 INHIBITORS; HALF-LIFE; MEGLUMINE; MICROSCOPY, POLARIZATION; NONLINEAR DYNAMICS; PHARMACEUTIC AIDS; POVIDONE; PYRAZOLES; SOLUBILITY; SULFONAMIDES; TEMPERATURE; THERMODYNAMICS; WATER;

EID: 28244474489     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aida K, Benino Y, Dimitrov V, Komatsu T (2000) Kinetics of enthalpy relaxation at the glass transition in ternary tellurite glasses. J Am Ceram Soc 83: 1192-1198.
2. Assman K, Schneider HA (1989) The thermal analysis of polymer blends of poly(ethylene oxide)/poly(methyl methacrylate). J Therm Anal 35: 459-468.
3. Chawla G, Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK (2003) Characterization of solid-state forms of celecoxib. Eur J Pharm Sci 20: 305-317.
4. Cowie J, Ferguson R (1989) Physical aging studies in poly(vinylmethyl ether). 1. Enthalpy relaxation as a function of aging temperature. Macromol 22: 2307-2312.
5. Craig DQM (2002) The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 231: 131-144.
6. Crowley KJ, Zografi G (2001) The use of thermal methods for predicting glass-former fragility. Thermochim Acta 380: 79-93.
7. Elamin AA, Ahlneck C, Alderbom G, Nystrom C (1994) Increased meta-stable solubility of milled griesofulvin, depending on the formation of a disordered surface structure. Int J Pharm 111: 159-170.
8. Fried JR, Karasz FE, MacKnight WJ (1978) Compatibility of poly(2,6-dimethyl-1,4-phenylene oxide) (ppo)/poly(styrene-co-4-chlorostyrene) blends. I. Differential scanning calorimetry and density studies. Macromol 11: 150-158.
9. Gupta P, Kakumanu VK, Bansal AK (2004a) Stability and solubility of celecoxib-PVP amorphous dispersions: A molecular perspective. Pharm Res 21: 1762-1769.
10. Gupta P, Chawla G, Bansal AK (2004b) Physical stability and solubility advantage from amorphous celecoxib: The role of thermodynamic quantities and molecular mobility. Mol Pharm 1: 406-413.
11. Hancock BC, Shamblin SL (2001) Molecular mobility of amorphous pharmaceuticals determined using differential scanning calorimetry. Thermochim Acta 380: 95-107.
12. Kakumanu VK, Bansal AK (2002) Enthalpy relaxation studies of celecoxib amorphous mixtures. Pharm Res 19: 1873-1878.
13. Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50: 47-60.
14. Loftsson T, Frioriksdottir H, Siguroardottir AM, Ueda H (1994) The effect of water-soluble polymers on drug-cyclodextrin complexation. Int J Pharm 110: 169-177.
15. Nandi I, Bateson M, Ban M, Joshi HN (2003) Synergistic effect of PEG-400 and cyclodextrin to enhance solubility of progesterone. AAPS PharmSciTech 4: 1-5.
16. Paulson SK, Vaughn MB, Jessen SM, Lawal Y, Gresk CJ, Van B, Maziasz TJ, Cook CS, Karim A (2001) Pharmacokinetics of celecoxib after oral administration in dogs and humans: Effect of food and site of absorption. J Pharmacol Expt Therap 297: 638-645.
17. Pikal MJ, Chang LL, Tang XC (2004) Evaluation of glassy-state dynamics from the width of the glass transition: Results from theoretical simulation of differential scanning calorimetry and comparisons with experiment. J Pharm Sci 93: 981-994.
18. Pomposo JA, Eguiazabal I, Calahorra E, Cortazar M (1993) Glass transition behaviour and interactions in poly(p-vinyl phenol)/polymethacrylate blends. Polymer 34: 95-102.
19. Press WH, Flannery BP, Teukolsky SA, Vetterling WT (1987) In: Numerical recipes, New York, p. 521-528.
20. Serajuddin ATM (1999) Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88: 1058-1066.
21. Sertosu G, Butler J, Hempenstall J, Rades T (2003) Physical stability and enthalpy relaxation of drug-hydroxypropyl methylcellulose phthalate solvent change co-precipitates. J Pharm Pharmacol 55: 35-41.
22. Sun D, Lennernas H, Welage LS, Barnett JL, Landowski CP, Foster D, Fleisher D, Lee K-D, Amidon GL (2002) Comparison of human duodenum and Caco-2gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res 19: 1400-1416.
23. Vachon MG, Grant DJW (1987) Enthalpy-entropy compensation in pharmaceutical solids. Int J Pharm 40: 1-14.
24. Yazdanian M, Briggs K, Jankovsky C, Hawi A (2004) The "high solubility" definition of the current FDA guidance on biopharmaceutical classification system may be too strict for acidic drugs. Pharm Res 21: 293-299.
25. Yu LX (1999) An integrated model for determining causes of poor oral drug absorption. Pharm Res 16: 1883-1887.
26. Yu LX, Amidon GL (1998) Characterization of small intestinal transit time distribution in humans. Int J Pharm 171: 157-163.